MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent.
Cell Death Dis. 2018 Feb 14;9(2):220
Authors: Wang T, Liu L, Chen X, Shen Y, Lian G, Shah N, Davidoff AM, Yang J, Wang R
Abstract Heightened aerobic glycolysis and glutaminolysis are characteristic metabolic phenotypes in cancer cells.